COL9A3

Chr 20ADAR

collagen type IX alpha 3 chain

Also known as: DJ885L7.4.1, EDM3, IDD, MED, STL6

This gene encodes one of the three alpha chains of type IX collagen, the major collagen component of hyaline cartilage. Type IX collagen, a heterotrimeric molecule, is usually found in tissues containing type II collagen, a fibrillar collagen. Mutations in this gene are associated with multiple epiphyseal dysplasia type 3. [provided by RefSeq, Jan 2010]

GeneReviewsOMIMResearchGenerating clinical summary…
MultiplemechanismAD/ARLOEUF 0.753 OMIM phenotypes
Clinical SummaryCOL9A3
🧬
Gene-Disease Validity (ClinGen)
Stickler syndrome · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
55 unique Pathogenic / Likely Pathogenic· 778 VUS of 1767 total submissions
📖
GeneReview available — COL9A3
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.75LOEUF
pLI 0.000
Z-score 3.00
OE 0.54 (0.400.75)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
-0.38Z-score
OE missense 1.05 (0.971.13)
471 obs / 448.2 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.54 (0.400.75)
00.351.4
Missense OE?1.05 (0.971.13)
00.61.4
Synonymous OE?1.21
01.21.6
LoF obs/exp: 27 / 49.9Missense obs/exp: 471 / 448.2Syn Z: -2.33
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongCOL9A3-related Stickler syndromeLOFAR
definitiveCOL9A3-related multiple epiphyseal dysplasiaDNAD

This gene — mechanism propensity

DN
0.86top 5%
GOF
0.6149th %ile
LOF
0.3164th %ile

The highest-scoring mechanism for this gene is dominant-negative.

DNprediction above median · 1 literature citation

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

DNThe novel phenotype of MED and mild myopathy is likely caused by a dominant-negative effect of the exon 3-skipping mutation in the COL9A3 gene.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

References

  1. 1.PMID 10655510

ClinVar Variant Classifications

1767 submitted variants in ClinVar

Classification Summary

Pathogenic38
Likely Pathogenic17
VUS778
Likely Benign758
Benign99
Conflicting59
38
Pathogenic
17
Likely Pathogenic
778
VUS
758
Likely Benign
99
Benign
59
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
37
0
1
0
38
Likely Pathogenic
12
2
3
0
17
VUS
43
646
68
21
778
Likely Benign
0
22
460
276
758
Benign
0
1
90
8
99
Conflicting
59
Total926716223051,749

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

31 pathogenic / likely-pathogenic (of 46) ClinVar copy-number / structural variants overlap COL9A3 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

COL9A3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →